Onyx Biotec Open Offer
VC Corporate Advisors filed a corrigendum to Onyx Biotec's open offer letter of offer. The offer seeks up to 47,14,372 shares, or 26% of paid-up capital.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
VC Corporate Advisors filed a corrigendum to Onyx Biotec's open offer letter of offer. The offer seeks up to 47,14,372 shares, or 26% of paid-up capital.
Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.
Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.
Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.